Annual CFF:
$255.62M+$122.05M(+91.37%)Summary
- As of today, DNTH annual cash from financing is $255.62 million, with the most recent change of +$122.05 million (+91.37%) on December 31, 2024.
- During the last 3 years, DNTH annual cash from financing has risen by +$166.02 million (+185.29%).
- DNTH annual cash from financing is now at all-time high.
Performance
DNTH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$274.51M+$273.94M(+48229.75%)Summary
- As of today, DNTH quarterly cash from financing is $274.51 million, with the most recent change of +$273.94 million (+48229.75%) on September 30, 2025.
- Over the past year, DNTH quarterly cash from financing has increased by +$274.22 million (+92640.88%).
- DNTH quarterly cash from financing is now at all-time high.
Performance
DNTH Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$314.92M+$274.22M(+673.74%)Summary
- As of today, DNTH TTM cash from financing is $314.92 million, with the most recent change of +$274.22 million (+673.74%) on September 30, 2025.
- Over the past year, DNTH TTM cash from financing has increased by +$103.84 million (+49.19%).
- DNTH TTM cash from financing is now -10.39% below its all-time high of $351.42 million, reached on March 31, 2024.
Performance
DNTH TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DNTH Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +91.4% | +10000.0% | +49.2% |
| 3Y3 Years | +185.3% | +184.1% | +225.3% |
| 5Y5 Years | +310.3% | +10000.0% | +366.7% |
DNTH Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +185.3% | at high | +5742.6% | -10.4% | +730.1% |
| 5Y | 5-Year | at high | +310.3% | at high | +5742.6% | -10.4% | >+9999.0% |
| All-Time | All-Time | at high | +2286.6% | at high | +5742.6% | -10.4% | >+9999.0% |
DNTH Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $274.51M(>+9900.0%) | $314.92M(+673.7%) |
| Jun 2025 | - | $568.00K(+252.8%) | $40.70M(+7.3%) |
| Mar 2025 | - | $161.00K(-99.6%) | $37.94M(-85.2%) |
| Dec 2024 | $255.62M(+91.4%) | $39.68M(>+9900.0%) | $255.62M(+21.1%) |
| Sep 2024 | - | $296.00K(+113.5%) | $211.08M(-39.6%) |
| Jun 2024 | - | -$2.20M(-101.0%) | $349.23M(-0.6%) |
| Mar 2024 | - | $217.85M(+4577.8%) | $351.42M(+163.1%) |
| Dec 2023 | $133.57M(+38.2%) | -$4.87M(-103.5%) | $133.57M(-3.5%) |
| Sep 2023 | - | $138.44M(>+9900.0%) | $138.44M(+43.3%) |
| Jun 2023 | - | $0.00(0.0%) | $96.63M(-0.1%) |
| Mar 2023 | - | $0.00(0.0%) | $96.68M(0.0%) |
| Dec 2022 | $96.68M(+7.9%) | $0.00(-100.0%) | $96.68M(-0.1%) |
| Sep 2022 | - | $96.63M(>+9900.0%) | $96.80M(>+9900.0%) |
| Jun 2022 | - | $49.00K(>+9900.0%) | $376.00K(-99.6%) |
| Mar 2022 | - | $0.00(-100.0%) | $89.18M(-0.5%) |
| Dec 2021 | $89.60M | - | - |
| Dec 2021 | - | $124.00K(-38.9%) | $89.60M(-1.2%) |
| Sep 2021 | - | $203.00K(-99.8%) | $90.66M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $88.86M(>+9900.0%) | $90.29M(+34.7%) |
| Mar 2021 | - | $418.00K(-64.5%) | $67.03M(-1.0%) |
| Dec 2020 | $67.74M(+8.7%) | $1.18M(+841.5%) | $67.74M(+0.4%) |
| Sep 2020 | - | -$159.00K(-100.2%) | $67.47M(-0.4%) |
| Jun 2020 | - | $65.59M(+5735.9%) | $67.73M(+7.7%) |
| Mar 2020 | - | $1.12M(+23.0%) | $62.86M(+0.9%) |
| Dec 2019 | $62.30M(-56.2%) | $914.00K(+862.1%) | $62.30M(+2.3%) |
| Sep 2019 | - | $95.00K(-99.8%) | $60.91M(+1.4%) |
| Jun 2019 | - | $60.73M(>+9900.0%) | $60.08M(-58.0%) |
| Mar 2019 | - | $563.00K(+218.3%) | $142.88M(+0.5%) |
| Dec 2018 | $142.15M(+98.8%) | -$476.00K(+34.9%) | $142.15M(-0.3%) |
| Sep 2018 | - | -$731.00K(-100.5%) | $142.62M(-1.9%) |
| Jun 2018 | - | $143.53M(>+9900.0%) | $145.35M(+123.3%) |
| Mar 2018 | - | -$175.00K(-108.8%) | $65.10M(-8.9%) |
| Dec 2017 | $71.49M(+567.4%) | - | - |
| Sep 2017 | - | $2.00M(-96.8%) | $71.49M(+2.9%) |
| Jun 2017 | - | $63.27M(+918.2%) | $69.49M(+1018.2%) |
| Mar 2017 | - | $6.21M | $6.21M |
| Dec 2016 | $10.71M | - | - |
FAQ
- What is Dianthus Therapeutics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. annual cash from financing year-on-year change?
- What is Dianthus Therapeutics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. quarterly cash from financing year-on-year change?
- What is Dianthus Therapeutics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Dianthus Therapeutics, Inc.?
- What is Dianthus Therapeutics, Inc. TTM cash from financing year-on-year change?
What is Dianthus Therapeutics, Inc. annual cash from financing?
The current annual cash from financing of DNTH is $255.62M
What is the all-time high annual cash from financing for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high annual cash from financing is $255.62M
What is Dianthus Therapeutics, Inc. annual cash from financing year-on-year change?
Over the past year, DNTH annual cash from financing has changed by +$122.05M (+91.37%)
What is Dianthus Therapeutics, Inc. quarterly cash from financing?
The current quarterly cash from financing of DNTH is $274.51M
What is the all-time high quarterly cash from financing for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high quarterly cash from financing is $274.51M
What is Dianthus Therapeutics, Inc. quarterly cash from financing year-on-year change?
Over the past year, DNTH quarterly cash from financing has changed by +$274.22M (+92640.88%)
What is Dianthus Therapeutics, Inc. TTM cash from financing?
The current TTM cash from financing of DNTH is $314.92M
What is the all-time high TTM cash from financing for Dianthus Therapeutics, Inc.?
Dianthus Therapeutics, Inc. all-time high TTM cash from financing is $351.42M
What is Dianthus Therapeutics, Inc. TTM cash from financing year-on-year change?
Over the past year, DNTH TTM cash from financing has changed by +$103.84M (+49.19%)